Evidence map›Paper›PMID 41888275›Full record

ArticleScientific reports2026

A lanmodulin homologous protein, from Mesorhizobium qingshengii J19, involved in yttrium immobilization.

Carina Coimbra, Paula V Morais, Rita Branco

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carina CoimbraCentre for Mechanical Engineering, Materials and Processes, ARISE, Department of Life Sciences, University of Coimbra, 3000-456, Coimbra, Portugal.
Paula V MoraisCentre for Mechanical Engineering, Materials and Processes, ARISE, Department of Life Sciences, University of Coimbra, 3000-456, Coimbra, Portugal. pvmorais@ci.uc.pt.
Rita BrancoCentre for Mechanical Engineering, Materials and Processes, ARISE, Department of Life Sciences, University of Coimbra, 3000-456, Coimbra, Portugal.

Funding

Agenda Microeletrónica C644916358-00000028AM2R 7253Arise Charitable Trust LA/P/0112/2020Center for Mechanical Engineering Materials and Processes UID/00285MSSHBioCem 2022.03631.PTDC
6 · The paper itself

Abstract

The increasing demand for rare earth elements (REEs) drives the need for sustainable recovery strategies, particularly those based on biological systems. Recent studies have highlighted the role of lanthanide series (LnIIIs) in bacterial processes, focusing on proteins capable of selectively recognizing and binding these metals. Among them, Lanmodulin (LanM) from Methylorubrum extorquens AM1, containing four EF-hand motifs, has been identified as highly selective for LnIII over calcium (Ca). Based on these findings, we studied a homologous EF-hand protein from Mesorhizobium qingshengii J19, a bacterium resistant to high concentrations of yttrium (Y). The corresponding gene was cloned and overexpressed in Escherichia coli BL21 to assess its metal-binding capabilities. Engineered cells co-incubated with neodymium (Nd) and Y exhibited increased accumulation of both metals. The purified recombinant protein matched the predicted molecular weight and was identified via Orbitrap-LC-MS as the EF-hand domain-containing protein. Protein-metal binding assays confirmed its affinity for Nd, while exhibiting higher levels for Y under the tested conditions. Overall, these results suggest that the EF-hand protein represents a promising bio-based tool for REE recovery and recycling from contaminated environments.

Indexed as

Bacterial ProteinsMesorhizobiumYttriumAmino Acid SequenceCloning, MolecularEF Hand MotifsEscherichia coliMetalloproteinsNeodymiumProtein BindingRecombinant ProteinsBacterial ProteinslanmodulinMetalloproteinsNeodymiumRecombinant ProteinsYttriumBioremediationLanmodulin homologMetal selectivityRare earth elementsY immobilization

Identifiers

PMID41888275
PMCPMC13172409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.